Home / BDNEWS / bdnews24.com - Home / Sanofi, GSK launch Phase III trial for their COVID-19 shot

Sanofi, GSK launch Phase III trial for their COVID-19 shot

May 27, 2021 BDNEWS, bdnews24.com - Home

France's Sanofi and Britain's GlaxoSmithKline on Thursday launched a late-stage human trial for their recombinant COVID-19 vaccine candidate that they hope to get approved by the end of this year.

from bdnews24.com - Home https://ift.tt/3yJGJbR

No comments

Subscribe to: Post Comments ( Atom )